131 related articles for article (PubMed ID: 1836485)
21. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting.
Villani ME; Morea V; Consalvi V; Chiaraluce R; Desiderio A; Benvenuto E; Donini M
Mol Immunol; 2008 May; 45(9):2474-85. PubMed ID: 18313757
[TBL] [Abstract][Full Text] [Related]
22. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
23. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
Boado RJ; Zhang Y; Zhang Y; Pardridge WM
Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
[TBL] [Abstract][Full Text] [Related]
24. Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen.
Beidler CB; Ludwig JR; Cardenas J; Phelps J; Papworth CG; Melcher E; Sierzega M; Myers LJ; Unger BW; Fisher M
J Immunol; 1988 Dec; 141(11):4053-60. PubMed ID: 3141512
[TBL] [Abstract][Full Text] [Related]
25. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
26. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M
Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725
[TBL] [Abstract][Full Text] [Related]
27. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
28. Recombinant mouse/human chimeric anti-colorectal carcinoma antibody cACT19.
Xiang J; Moyana T; Liu E
Hum Antibodies Hybridomas; 1994; 5(3-4):105-15. PubMed ID: 7756575
[TBL] [Abstract][Full Text] [Related]
29. Humanization of Immu31, an alpha-fetoprotein-specific antibody.
Qu Z; Losman MJ; Eliassen KC; Hansen HJ; Goldenberg DM; Leung SO
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3095s-3100s. PubMed ID: 10541349
[TBL] [Abstract][Full Text] [Related]
30. Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1.
Werther WA; Gonzalez TN; O'Connor SJ; McCabe S; Chan B; Hotaling T; Champe M; Fox JA; Jardieu PM; Berman PW; Presta LG
J Immunol; 1996 Dec; 157(11):4986-95. PubMed ID: 8943405
[TBL] [Abstract][Full Text] [Related]
31. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments.
Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S
J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465
[TBL] [Abstract][Full Text] [Related]
32. Failure of anti-T-cell receptor V beta antibodies to consistently identify a malignant T-cell clone in Sézary syndrome.
Bigler RD; Boselli CM; Foley B; Vonderheid EC
Am J Pathol; 1996 Nov; 149(5):1477-83. PubMed ID: 8909237
[TBL] [Abstract][Full Text] [Related]
33. Engineered anti-CD38 monoclonal antibodies for immunotherapy of multiple myeloma.
Ellis JH; Barber KA; Tutt A; Hale C; Lewis AP; Glennie MJ; Stevenson GT; Crowe JS
J Immunol; 1995 Jul; 155(2):925-37. PubMed ID: 7608568
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of induction immunosuppression with a murine IgG2b monoclonal antibody (BMA 031) directed toward the human alpha/beta-T cell receptor.
Knight RJ; Kurrle R; McClain J; Racenberg J; Baghdahsarian V; Kerman R; Lewis R; van Buren CT; Kahan BD
Transplantation; 1994 Jun; 57(11):1581-8. PubMed ID: 8009591
[TBL] [Abstract][Full Text] [Related]
35. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
Wang Y; Li X; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
[TBL] [Abstract][Full Text] [Related]
36. [Preparation of human Fab antibodies against HAb18G by guided selection and chain shuffling technique].
Bao GQ; Ma QJ; Xing JL; Yang XM; Chen ZN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):437-40. PubMed ID: 15207089
[TBL] [Abstract][Full Text] [Related]
37. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
Protopapadakis E; Kokla A; Tzartos SJ; Mamalaki A
Eur J Immunol; 2005 Jun; 35(6):1960-8. PubMed ID: 15915538
[TBL] [Abstract][Full Text] [Related]
38. Construction and characterization of a humanized anti-gamma-Ig receptor type I (Fc gamma RI) monoclonal antibody.
Graziano RF; Tempest PR; White P; Keler T; Deo Y; Ghebremariam H; Coleman K; Pfefferkorn LC; Fanger MW; Guyre PM
J Immunol; 1995 Nov; 155(10):4996-5002. PubMed ID: 7594506
[TBL] [Abstract][Full Text] [Related]
39. [Construction of expression vector for human-mouse chimeric antibody and expression of an antibody against human HER2].
Wang LL; Han H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):363-5. PubMed ID: 15193240
[TBL] [Abstract][Full Text] [Related]
40. A humanized antibody specific for the platelet integrin gpIIb/IIIa.
Co MS; Yano S; Hsu RK; Landolfi NF; Vasquez M; Cole M; Tso JT; Bringman T; Laird W; Hudson D
J Immunol; 1994 Mar; 152(6):2968-76. PubMed ID: 8144896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
